Royal Bank of Canada’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-91
| Closed | -$1K | – | 7740 |
|
|
2025
Q4 | $1K | Sell |
91
-444
| -83% | -$3.32K | ﹤0.01% | 7057 |
|
|
2025
Q3 | $1K | Buy |
535
+453
| +552% | +$1.2K | ﹤0.01% | 7035 |
|
|
2025
Q2 | $0 | Sell |
82
-4,372
| -98% | -$7.06K | ﹤0.01% | 7380 |
|
|
2025
Q1 | $5K | Sell |
4,454
-23,692
| -84% | -$40.7K | ﹤0.01% | 6375 |
|
|
2024
Q4 | $62K | Buy |
28,146
+21,783
| +342% | +$49.4K | ﹤0.01% | 5589 |
|
|
2024
Q3 | $14K | Buy |
6,363
+647
| +11% | +$1.49K | ﹤0.01% | 6238 |
|
|
2024
Q2 | $13K | Sell |
5,716
-873
| -13% | -$3.63K | ﹤0.01% | 6256 |
|
|
2024
Q1 | $37K | Sell |
6,589
-45,183
| -87% | -$207K | ﹤0.01% | 5663 |
|
|
2023
Q4 | $128K | Buy |
51,772
+45,913
| +784% | +$436K | ﹤0.01% | 5466 |
|
|
2023
Q3 | $203K | Sell |
5,859
-6,694
| -53% | -$231K | ﹤0.01% | 4791 |
|
|
2023
Q2 | $411K | Buy |
12,553
+11,159
| +801% | +$385K | ﹤0.01% | 4104 |
|
|
2023
Q1 | $47K | Sell |
1,394
-1,989
| -59% | -$77.3K | ﹤0.01% | 5658 |
|
|
2022
Q4 | $111K | Sell |
3,383
-2,239
| -40% | -$66.3K | ﹤0.01% | 5371 |
|
|
2022
Q3 | $197K | Buy |
5,622
+5,495
| +4,327% | +$122K | ﹤0.01% | 4794 |
|
|
2022
Q2 | $2K | Sell |
127
-514
| -80% | -$7.68K | ﹤0.01% | 7007 |
|
|
2022
Q1 | $9K | Sell |
641
-1,440
| -69% | -$19.2K | ﹤0.01% | 7012 |
|
|
2021
Q4 | $41K | Buy |
+2,081
| New | +$39.4K | ﹤0.01% | 6488 |
|
Other funds holding VTYX
Royal Bank of Canada's VTYX Position: Q1 2026 in Review
Royal Bank of Canada sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 91 shares — an estimated $1K sold.
Royal Bank of Canada first reported a position in VTYX in Q4 2021 and held it in 17 quarters. The position peaked at $411K in Q2 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.
- Royal Bank of Canada reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
- Royal Bank of Canada sold 91 Ventyx Biosciences shares in Q1 2026, an estimated $1K.
- Royal Bank of Canada first reported a position in Ventyx Biosciences in Q4 2021 and held it in 17 quarters.
- Royal Bank of Canada's Ventyx Biosciences position peaked at $411K in Q2 2023.
- 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.